According to an SEC filing, behavioral health analytics startup Ginger.io has added $20 million in Series B funding. This brings the total amount raised up to $28.2 million.
According to the filing, Ginger.io added Kaiser Permanente Ventures partner Dave Schulte to its board. This usually implies the new investor also led the round. Romulus Capital, Khosla Ventures and True Ventures participated in an earlier round of financing.
It’s also worth noting that Kaiser is a partner already, but having a more strategic relationship could help Ginger.io become more widely used in hospitals.
The startup also partners with several medical institutions, including UCSF, Massachusetts General Hospital, Brigham and Women’s Hospital, and McLean Hospital, Duke University, UC Davis and University of Nebraska Medical Center.
Ginger.io launched a grant-funded program to help low-income people suffering from depression in Utah earlier this year.